X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
0
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
https://www.globenewswire.com/news-release/2024/04/30/2872179/0/en/Eagle-Pharmaceuticals-Announces-a-Trial-in-Progress-Presentation-of-Phase-2-3-Study-of-Intravenous-Amisulpride-as-Prevention-of-Postoperative-Nausea-and-Vomiting-in-Pediatric-Patie.html
https://www.globenewswire.com/news-release/2024/04/15/2862631/0/en/Eagle-Pharmaceuticals-to-Present-Additional-Data-from-Phase-III-Trial-Demonstrating-Sustained-Response-of-Amisulpride-for-the-Rescue-Treatment-of-Postoperative-Nausea-and-Vomiting-.html
https://www.globenewswire.com/news-release/2023/12/06/2792093/0/en/Eagle-Pharmaceuticals-to-Present-Abstract-on-Post-hoc-Analysis-of-Amisulpride-at-the-77th-PGA-PostGraduate-Assembly-in-Anesthesiology-in-New-York-City.html
https://www.globenewswire.com/news-release/2021/09/29/2305003/0/en/Acacia-Pharma-Announces-Submission-and-Validation-of-Marketing-Authorization-Application-for-BARHEMSYS-amisulpride-injection-in-Major-European-Markets.html
http://www.pharmafile.com/news/589028/acacia-pharma-s-new-cancer-care-injection-approved-europe
https://www.globenewswire.com/news-release/2020/08/24/2082317/0/en/BARHEMSYS-amisulpride-injection-Launched-in-the-US-for-the-Treatment-and-Prevention-of-PONV.html
https://endpts.com/acacia-pharmas-first-drug-finally-makes-the-fda-cut/
https://www.fiercepharma.com/manufacturing/acacia-twice-foiled-by-manufacturing-crls-gets-2020-pdfua-after-bringing-new-api
http://www.pmlive.com/pharma_news/acacia_eyes_february_fda_verdict_for_refiled_nausea_drug_barhemsys_1302675
https://www.in-pharmatechnologist.com/Article/2019/05/07/Nausea-drug-candidate-receives-second-CRL
https://www.in-pharmatechnologist.com/Article/2019/05/07/Nausea-drug-candidate-receives-second-CRL
https://www.nasdaq.com/press-release/acacia-pharma-provides-further-update-on-fda-regulatory-review-of-barhemsystm-20181015-00017
http://www.pharmatimes.com/news/acacias_ponv_drug_under_us_review_1215810
https://www.prnewswire.com/news-releases/acacia-pharma-announces-fda-acceptance-of-nda-filing-for-baremsis-for-the-management-of-post-operative-nausea--vomiting-667996153.html
http://www.prnewswire.com/news-releases/acacia-pharma-announces-positive-results-from-second-pivotal-phase-3-study-of-baremsis-apd421-in-prevention-of-post-operative-nausea--vomiting-564208971.html
http://www.prnewswire.com/news-releases/acacia-pharma-announces-positive-results-from-second-pivotal-phase-3-study-of-baremsis-apd421-in-prevention-of-post-operative-nausea--vomiting-564208971.html
Market Place
Share 
